Biogen Inc. (BIIB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Biogen Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 19.96x | 13.65x | 32.25x | 13.21x | 22.99x | 9.85x |
| P/B Ratio | 1.41x | 1.33x | 2.53x | 3.00x | 3.28x | 3.68x |
| P/S Ratio | 2.63x | 2.30x | 3.81x | 3.96x | 3.26x | 2.93x |
| Profitability | ||||||
| Gross Margin | 70.5% | 76.1% | 74.2% | 77.6% | 80.8% | 86.6% |
| Operating Margin | 19.1% | 25.7% | 21.3% | 28.4% | 25.4% | 34.2% |
| Net Margin | 13.2% | 16.9% | 11.8% | 29.9% | 14.2% | 29.8% |
| EBITDA Margin | 31.6% | 31.0% | 24.2% | 34.8% | 35.7% | 38.0% |
| Liquidity | ||||||
| Current Ratio | 2.68x | 1.35x | 2.00x | 2.99x | 1.83x | 1.84x |
| Quick Ratio | 2.03x | 0.90x | 1.26x | 2.58x | 1.51x | 1.55x |
| Leverage | ||||||
| Debt/Equity | 0.38x | 0.40x | 0.50x | 0.49x | 0.70x | 0.73x |
YoY = year-over-year change. Source: FMP..